171 related articles for article (PubMed ID: 9816747)
21. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
22. Drug combination shows benefits for AIDS patients with history of taking AZT.
AIDS Patient Care STDS; 1996 Jun; 10(3):185-6. PubMed ID: 11361628
[No Abstract] [Full Text] [Related]
23. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
[TBL] [Abstract][Full Text] [Related]
24. Standard treatments for HIV, Spring 1997.
Smith D
AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255
[TBL] [Abstract][Full Text] [Related]
25. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
[No Abstract] [Full Text] [Related]
26. HIV: it's beginning to look like a chronic disease.
del Rio C
AIDS Clin Care; 2001 Sep; 13(9):82-3. PubMed ID: 11547601
[No Abstract] [Full Text] [Related]
27. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
[TBL] [Abstract][Full Text] [Related]
28. ACTG 320 trial halted as three-drug arm proves superior.
AIDS Patient Care STDS; 1997 Jun; 11(3):194. PubMed ID: 11361796
[No Abstract] [Full Text] [Related]
29. Therapies. Confronting the limits of success.
Cohen J
Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
[No Abstract] [Full Text] [Related]
30. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
Murphy RL
Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
[TBL] [Abstract][Full Text] [Related]
31. A pilot study of a combination of three reverse transcriptase inhibitors in HIV-1 infection.
Lafeuillade A; Poggi C; Djediouane A; Chollet L; Profizi N; Sayada C
Antivir Ther; 1997 Dec; 2(4):219-27. PubMed ID: 11327441
[TBL] [Abstract][Full Text] [Related]
32. Role of viral load blips, drug boosting, and therapeutic holidays in HIV patient management.
Bean P
Am Clin Lab; 2001 Sep; 20(8):11-3. PubMed ID: 11586932
[No Abstract] [Full Text] [Related]
33. New treatment options.
Fornataro K; Jefferys R
Body Posit; 1999 Jun; 12(6):11-2. PubMed ID: 11367013
[TBL] [Abstract][Full Text] [Related]
34. Targeting a deadly scrap of genetic code.
Cowley G
Newsweek; 1996 Dec; 128(23):68-9. PubMed ID: 10162944
[No Abstract] [Full Text] [Related]
35. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.
Hoffmann F; Funk M; Linde R; Notheis G; Petropoulou T; Eberle J; Gürtler L; Belohradsky BH; Wintergerst U
Eur J Med Res; 2002 Jul; 7(7):330-4. PubMed ID: 12176683
[TBL] [Abstract][Full Text] [Related]
36. Choosing the right initial antiretroviral regimens.
Norton M
GMHC Treat Issues; 1999 Feb; 13(2):7-10. PubMed ID: 11366117
[TBL] [Abstract][Full Text] [Related]
37. Phase II/III Trials of Viracept start.
AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361632
[No Abstract] [Full Text] [Related]
38. Clinical evaluation of the efficacy and tolerability of ritonavir in combination with two reverse transcriptase inhibitors.
Gomes de Arruda EA; Pedrosa De Oliveira Júnior FR; Martins Maia F; Ary Duque I
Braz J Infect Dis; 2000 Feb; 4(1):29-35. PubMed ID: 10788843
[TBL] [Abstract][Full Text] [Related]
39. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
[No Abstract] [Full Text] [Related]
40. Anti-HIV drug update.
Proj Inf Perspect; 2000 Aug; (30):5-6. PubMed ID: 12171015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
